The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of PTC Therapeutics Inc (NASDAQ: PTCT) closed at $49.99 in the last session, up 1.24% from day before closing price of $49.38. In other words, the price has increased by $1.24 from its previous closing price. On the day, 0.89 million shares were traded. PTCT stock price reached its highest trading level at $50.61 during the session, while it also had its lowest trading level at $49.265.
Ratios:
We take a closer look at PTCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on December 13, 2024, Upgraded its rating to Overweight and sets its target price to $67 from $45 previously.
On December 03, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $39 to $63.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 03 ’25 when Bell William F. Jr. bought 10,556 shares for $50.00 per share.
Utter Christine Marie sold 1,662 shares of PTCT for $73,959 on Jan 08 ’25. The SVP, CHIEF ACCOUNTING OFFICER now owns 64,321 shares after completing the transaction at $44.50 per share. On Jan 07 ’25, another insider, Utter Christine Marie, who serves as the SVP, CHIEF ACCOUNTING OFFICER of the company, sold 1,291 shares for $45.34 each. As a result, the insider received 58,534 and left with 65,983 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3855484160 and an Enterprise Value of 5314356736. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.28. Its current Enterprise Value per Revenue stands at 5.9 whereas that against EBITDA is 243.242.
Stock Price History:
The Beta on a monthly basis for PTCT is 0.69, which has changed by 0.95564353 over the last 52 weeks, in comparison to a change of 0.208081 over the same period for the S&P500. Over the past 52 weeks, PTCT has reached a high of $54.16, while it has fallen to a 52-week low of $23.58. The 50-Day Moving Average of the stock is 8.33%, while the 200-Day Moving Average is calculated to be 31.67%.
Shares Statistics:
According to the various share statistics, PTCT traded on average about 744.43K shares per day over the past 3-months and 747470 shares per day over the past 10 days. A total of 76.95M shares are outstanding, with a floating share count of 75.41M. Insiders hold about 2.23% of the company’s shares, while institutions hold 101.73% stake in the company. Shares short for PTCT as of 1736899200 were 4240687 with a Short Ratio of 5.70, compared to 1734048000 on 4590192. Therefore, it implies a Short% of Shares Outstanding of 4240687 and a Short% of Float of 8.55.
